L & S Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
L & S Advisors's GILD Position: Q1 2026 in Review
L & S Advisors increased its Gilead Sciences (GILD) stake by 81% in Q1 2026, buying an estimated $4.73M and bringing the position to 75,255 shares worth $10.5M. The position accounts for 1.32% of the portfolio, ranked #20.
L & S Advisors first reported a position in GILD in Q2 2013 and has held it in 14 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- L & S Advisors held 75,255 shares of Gilead Sciences worth $10.5M as of Q1 2026.
- L & S Advisors bought 33,789 Gilead Sciences shares in Q1 2026, an estimated $4.73M.
- Gilead Sciences made up 1.32% of L & S Advisors's portfolio in Q1 2026, its #20 holding.
- L & S Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 14 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on L & S Advisors's 13F filing for Q1 2026, filed 11 May 2026.